BI 653048 BS H3PO4 Capsule
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI 653048 BS H3PO4 Capsule, covering 2014-08-15 to 2014-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects [Phase 1]